Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 284 of 5804
-
New drug aims to boost height in kids with dwarfism
Disease control Recruiting nowThis is a multicenter, multinational, randomized, active-controlled, operationally seamless Phase 2/3 study of BMN 333 in treatment-naïve pediatric participants with achondroplasia (ACH). The study consists of a Phase 2 part and a Phase 3 part.
Phase: PHASE2, PHASE3 • Sponsor: BioMarin Pharmaceutical • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
A gentle touch may soothe Preemies' pain during blood tests
Symptom relief Recruiting nowPremature infants frequently experience painful procedures during their admission to neonatal intensive care units; this can lead to acute adverse events, imbalances, and long-term neurodevelopmental implications. This randomized controlled trial evaluates the impact of Gentle Hu…
Phase: NA • Sponsor: Kubra Nur Kabakcı Sarıdağ • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
New drug aims to protect lungs in autoimmune patients
Disease control Not yet recruitingInterstitial lung disease (ILD) is a common pulmonary manifestation in chronic tissue diseases (CTD), significantly affecting patient's prognosis. The main purpose of this study is to evaluate the efficacy of telitacicept compared with placebo in slowing down the decline in lung…
Phase: PHASE3 • Sponsor: RemeGen Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Could J147 help stroke patients recover better?
Disease control Not yet recruitingThe goal of this clinical trial is to find out if the drug J147 improves outcomes for persons who have had an ischemic stroke. It also will learn about the safety of J147 when given by injection to stroke patients. Researchers will compare the outcomes of those who receive J147 a…
Phase: PHASE2 • Sponsor: Abrexa Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New combo therapy aims to stall advanced lung cancer
Disease control Not yet recruitingThis study intends to carry out prospective, randomized controlled clinical trials in many centers across the country to compare the efficacy and safety of immunotherapy after standard first-line chemotherapy or immunotherapy combined with interventional bronchial artery chemoemb…
Phase: PHASE4 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New eye drug aims to block two causes of vision loss at once
Disease control Not yet recruitingOculgen has begun a study of an investigational drug called OCUL101 as a possible treatment for neovascular AMD. An investigational drug is one that has not been approved by regulatory agencies, such as the Food and Drug Administration (FDA) in the United States (US), the Europea…
Phase: PHASE2, PHASE3 • Sponsor: Shenzhen Oculgen Biomedical Technology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Bionic arm breakthrough? new implant aims for natural control
Disease control Recruiting nowThe CYBORG Study is a first-in-human clinical investigation evaluating the safety and performance of the Phantom X System, an implantable electromyography (EMG) sensor array designed to provide control of upper-limb prostheses. The study will assess surgical feasibility, device f…
Phase: NA • Sponsor: Phantom Neuro Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New drug combo aims to wipe out stomach cancer before surgery
Disease control Recruiting nowThis study is a prospective, randomized, open, multicenter phase II clinical trial. It plans to enroll 70 participants with locally advanced gastric and gastroesophageal junction adenocarcinoma (G/GEJ AC) who are assessed as suitable for D2 radical surgery and capable of R0 resec…
Phase: PHASE2 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Could a diabetes drug curb heavy drinking in HIV patients?
Disease control Recruiting nowThe goal of this clinical trial is to learn if the drug semaglutide works to reduce alcohol intake among adults living with HIV. The main questions it aims to answer are: 1. Does semaglutide lower the average number of alcoholic beverages participants drink per week? 2. Does sem…
Phase: PHASE2 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New drug azenosertib takes on Chemo-Resistant ovarian cancer in phase 3 trial
Disease control Recruiting nowThis is a randomized, Phase 3 trial designed to evaluate the efficacy and safety of azenosertib compared to Investigator's choice of chemotherapy in subjects with platinum-resistant ovarian cancer whose tumors are positive for cyclin E1 protein expression.
Phase: PHASE3 • Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New hope for stomach cancer patients with abdominal spread
Disease control Recruiting nowIn this study, the investigators will use LM-302 and S-1 plus intraperitoneal paclitaxel with or without Cadonilimab to treat Claudin 18.2-positive gastric or gastroesophageal junction adenocarcinoma with peritoneal metastasis.
Phase: PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New drug shows promise for tough liver cancer cases
Disease control Recruiting nowThis study will evaluate the efficacy and safety of Becotatug vedotin, MRG003, in previously treated advanced hepatocellular carcinoma (HCC).
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can immunotherapy stop colorectal Cancer's return?
Disease control Recruiting nowThe NSABP FC-13 study is being done to determine if using immunotherapies alone or in combination with other drugs will delay or prevent colorectal cancer from coming back in patients with colorectal cancer who are ctDNA-positive after their treatment. Immunotherapeutic drugs (im…
Phase: PHASE2 • Sponsor: NSABP Foundation Inc • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New cocktail of drugs hopes to tackle tough breast cancer
Disease control Recruiting nowThis study is a single-arm, multicenter, prospective phase II clinical trial designed to evaluate the efficacy and safety of QL1706 in combination with anlotinib hydrochloride and nab-paclitaxel as first-line treatment for advanced triple-negative breast cancer. A total of 34 pa…
Phase: PHASE2 • Sponsor: Jiangsu Cancer Institute & Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Gene therapy could free kids from lifelong blood transfusions
Disease control Recruiting nowBrief summary The goal of this clinical trial is to learn if APR-2020 is safe and can help treat Diamond-Blackfan Anemia (DBA) in adolescents and children. The main questions it aims to answer are: * Is APR-2020 safe and well tolerated? * Does APR-2020 modify or correct an unde…
Phase: PHASE1 • Sponsor: Apriligen, Inc. • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New hope for kidney transplant patients: extended drug trial targets rejection
Disease control ENROLLING_BY_INVITATIONIn this study, researchers will learn more about a drug called felzartamab in people who have received a kidney transplant and then developed antibody-mediated rejection (AMR) or microvascular inflammation (MVI). AMR happens when the body's immune system creates donor-specific an…
Phase: PHASE3 • Sponsor: Biogen • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New drug aims to stop chemo hair loss in its tracks
Prevention Not yet recruitingClinical Study of DA-020 as a Treatment for Chemotherapy Induced Alopecia
Phase: PHASE1, PHASE2 • Sponsor: Applied Biology, Inc. • Aim: Prevention
Last updated Jun 27, 2026 12:06 UTC
-
Smart drug delivers chemo directly to cancer cells in new trial
Disease control Recruiting nowThis is a Phase 1/2a open-label multicenter study to evaluate the safety, efficacy, and pharmacokinetics of CKD-703 in Advanced c-Met Expressing Solid Tumors, and in MET-Amplified and c-Met Overexpressing Non-Small Cell Lung Cancer. CKD-703 is composed of a c-Met-targeting monoc…
Phase: PHASE1, PHASE2 • Sponsor: Chong Kun Dang Pharmaceutical • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New combo aims to shrink MALT lymphoma with less radiation damage
Disease control Recruiting nowThis is a prospective, multicenter Phase 2 clinical trial named the MALT-RO study, evaluating ultra-low-dose radiation therapy followed by orelabrutinib as first-line treatment for adults with Stage I-II MALT lymphoma. The study aims to determine the efficacy and safety profile o…
Phase: PHASE2 • Sponsor: Zhejiang Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Can stem cells heal burn scars? new trial aims to find out
Disease control Recruiting nowThe present project serves to test whether stem cell therapy offers a new treatment option for the scars of burn survivors. In Denmark, 12.000 people seek medical assistance every year for burn injuries leaving thousands of people with the devastating condition of hypertrophic sc…
Phase: PHASE1, PHASE2 • Sponsor: Rigshospitalet, Denmark • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC